Treating hypertension with beta blockers: the European Sleep Apnea Database

Affiliations

Editorial

Athanasios J Manolis et al. J Hypertens. 2021.

. 2021 Feb 1;39(2):231-233.

doi: 10.1097/HJH.0000000000002653.

No abstract available

Comment on

Superior hypertension control with betablockade in the European Sleep Apnea Database.
Svedmyr S, Hedner J, Zou D, Parati G, Ryan S, Hein H, Pepin JL, Tkáčová R, Marrone O, Schiza S, Basoglu OK, Grote L; European Sleep Apnea Database (ESADA) study group. Svedmyr S, et al. J Hypertens. 2021 Feb 1;39(2):292-301. doi: 10.1097/HJH.0000000000002629. J Hypertens. 2021. PMID: 33031170

1. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical Practice Guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13:479–504.
1. Manolis AJ, Poulimenos LE, Kallistratos MS, Gavras I, Gavras H. Sympathetic overactivity in hypertension and cardiovascular disease. Curr Vasc Pharmacol 2014; 12:4–15.
1. Kallistratos MS, Poulimenos LE, Tsinivizov P, Dimitris V, Kouremenos N, Pittaras A, et al. The effect of mid-day sleep on blood pressure levels in patients with arterial hypertension. Eur J Intern Med 2020; S0953-6205:30215–30216.
1. Seravalle G, Mancia G, Grassi G. Sympathetic nervous system, sleep, and hypertension. Curr Hypertens Rep 2018; 20:74.
1. Manolis AJ, Kallistratos MS, Vlahakos DV, Mitrakou A, Poulimenos LE. Coca A. Comorbidities often associated with brain damage in hypertension: diabetes, coronary artery disease, chronic kidney disease and obstructive sleep apnoea. Springer, Hypertension and brain damage. Updates in hypertension and cardiovascular protection. . Cham:2016.